Synthetic Biology

UCLA Advances CAR-T Therapy for Pediatric Bone Cancer
Tech & Innovation UCLA Advances CAR-T Therapy for Pediatric Bone Cancer

While significant progress has been made in the treatment of many childhood illnesses, pediatric bone cancer continues to present a formidable obstacle for oncologists and researchers alike. Dr. Theodore Scott Nowicki, a prominent researcher at UCLA, was recently recognized for his innovative

Can Hookworms Be Reprogrammed as Living Drug Factories?
Research & Development Can Hookworms Be Reprogrammed as Living Drug Factories?

The transformation of human hookworms from harmful intestinal parasites into sophisticated, living drug factories represents one of the most radical shifts in modern bioengineering and therapeutic delivery. While these organisms have historically been associated with disease and malnutrition in

Can CRISPR and Serum-Free Media Scale Lab-Grown Pork?
Biotech & Bioprocessing Can CRISPR and Serum-Free Media Scale Lab-Grown Pork?

The global demand for high-quality protein continues to drive the pursuit of sustainable alternatives that bypass traditional animal husbandry while maintaining the sensory characteristics of authentic meat. Cultivated pork represents a significant frontier in food technology, yet the industry

Can Synthetic Biology Lead the Next Industrial Revolution?
Management & Regulatory Can Synthetic Biology Lead the Next Industrial Revolution?

The ability to reprogram living organisms to produce high-value chemicals and materials has transitioned from a niche academic pursuit to the cornerstone of a new economic paradigm. Instead of relying on the extraction of finite fossil fuels, industries are increasingly looking toward the

DNA Hydrogel Breakthrough Accelerates Complex Bone Healing
Research & Development DNA Hydrogel Breakthrough Accelerates Complex Bone Healing

Surgeons have long struggled with the intricate biological demands of repairing massive skeletal defects where traditional bone grafts often fail due to poor integration or limited availability of donor tissue. In the current landscape of regenerative medicine, the pursuit of a biocompatible

Why Are AI Giants Demanding Tighter Biosecurity Laws?
Tech & Innovation Why Are AI Giants Demanding Tighter Biosecurity Laws?

The rapid evolution of generative artificial intelligence has fundamentally altered the accessibility of complex biological data, raising urgent concerns among developers about the potential for these tools to be misused in the creation of dangerous pathogens. While AI companies have traditionally

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later